DNA FORENSIC MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

The global DNA forensic market size is expected to stand at USD 3.60 Bn in 2026 and is projected to reach USD 6 Bn by 2033, expanding at a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033. The global DNA forensic market encompasses a broad range of products, services, and technologies, including DNA extraction kits, amplification systems, capillary electrophoresis instruments, next-generation sequencing platforms, and bioinformatics software utilized across law enforcement agencies, forensic laboratories, academic institutions, and healthcare organizations. The rising incidence of violent crimes, increasing government investments in forensic infrastructure, and continuous technological advancements in genomics and molecular biology have collectively propelled market expansion across developed and emerging economies.

Market Dynamics

The global DNA forensic market is experiencing robust growth, primarily driven by the escalating demand for accurate and reliable crime investigation tools, expanding forensic laboratory infrastructure, and heightened governmental focus on public safety and criminal justice reform. Law enforcement agencies worldwide are increasingly adopting advanced DNA profiling technologies to enhance conviction rates, exonerate wrongfully accused individuals, and maintain comprehensive criminal DNA databases, thereby generating consistent demand for innovative forensic solutions. The rapid integration of next-generation sequencing (NGS) and rapid DNA analysis technologies has significantly shortened turnaround times for forensic results, further encouraging widespread adoption across police departments, border control agencies, and judicial bodies

However, the market faces notable restraints, particularly concerning privacy and ethical concerns surrounding the collection, storage, and utilization of genetic data, which have triggered stringent regulatory scrutiny across several jurisdictions, potentially limiting database expansion initiatives. High instrument and operational costs associated with advanced forensic DNA platforms also pose significant barriers to adoption, especially among underfunded forensic laboratories in developing nations, thereby constraining overall market penetration. Furthermore, the shortage of trained forensic scientists and analysts capable of interpreting complex genetic data remains a persistent challenge hampering operational efficiency across forensic units globally.

Key Features of the Study

• This report provides in-depth analysis of the global DNA forensic market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global DNA forensic market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific, QIAGEN, Promega Corporation, Illumina, Abbott, Agilent Technologies, Bio-Rad Laboratories, Eurofins Scientific, LGC Forensics, Verogen, Bode Technology, DNA Diagnostics Center, Takara Bio, Othram, InVita Healthcare Technologies
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global DNA forensic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global DNA forensic market

Market Segmentation

• Component Insights (Revenue, USD Billion, 2021 - 2033)
  • Consumables
  • Analyzers and Sequencers
  • Software
  • Services
• Method Insights (Revenue, USD Billion, 2021 - 2033)
  • Polymerase Chain Reaction Amplification
  • Capillary Electrophoresis
  • Next Generation Sequencing
  • Others
• Application Insights (Revenue, USD Billion, 2021 - 2033)
  • Criminal Testing
  • Paternity and Familial Testing
  • Disaster Victim Identification
  • Others
• End User Insights (Revenue, USD Billion, 2021 - 2033)
  • Law Enforcement Agencies
  • Forensic Laboratories
  • Research Institutions
  • Medical and Research Institutions
  • Legal and Judicial Systems
  • Others
• Regional Insights (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Thermo Fisher Scientific
  • QIAGEN
  • Promega Corporation
  • Illumina
  • Abbott
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Eurofins Scientific
  • LGC Forensics
  • Verogen
  • Bode Technology
  • DNA Diagnostics Center
  • Takara Bio
  • Othram
  • InVita Healthcare Technologies